COMORBIDITIES AND CPGs FOR CARDIOVASCULAR CONDITIONS
CPGs jointly developed by the AHA/ACC are cardiovascular diseaseÀspecific documents focused on the prevention, diagnosis, and management of conditions such as ischemic heart disease, heart failure, and atrial fibrillation. These CPGs often contain considerations for special factors (e.g., older adults) and common problems affecting pharmacokinetics (e.g., renal impairment). For example, the 2014 CPG on atrial fibrillation (7) highlights special considerations for acute myocardial infarction, pregnancy, hyperthyroidism, and other conditions. With the exception of the CPGs on atrial fibrillation and heart failure (7, 
PREVALENCE OF COMORBIDITIES AMONG PATIENTS PRESENTING WITH INDEX CARDIOVASCULAR CONDITIONS
To assess the frequency of comorbidities, the 10 most common comorbid conditions among Medicare beneficiaries were identified using CMS administrative enrollment and claims data (13) for 4 index cardiovascular conditions: ischemic heart disease, heart failure, atrial fibrillation, and stroke. Table 1 shows the 10 most common comorbidities for each index cardiovascular condition for beneficiaries ‡65 years of age in 2012 (13). The numbers of Medicare beneficiaries with the 4 index cardiovascular conditions were 8,678,060 with ischemic heart disease, 4,366,489 with heart failure, 2,556,839 with atrial fibrillation, and 1,145,719 with stroke. Two conditions that are major cardiovascular risk factors-hypertension and hyperlipidemia-constitute the most frequent dyad. Hypertension, hyperlipidemia, and ischemic heart disease were the 3 most prevalent comorbidities for patients with heart failure, atrial fibrillation, and stroke, whereas hypertension, hyperlipidemia, and diabetes mellitus were the most prevalent comorbidities in those with ischemic heart disease; however, arthritis, anemia, chronic obstructive pulmonary disease, and Alzheimer's disease also appeared. Table 2 lists the top 5 most prevalent dyad and triad comorbidities for beneficiaries ‡65 years of age with at least 2 (for dyads) or 3 (for triads) chronic conditions.
Combinations of high cholesterol, high blood pressure, and ischemic heart disease were most frequently represented in the dyads and triads, with diabetes mellitus and arthritis completing the remaining prevalent combinations (14). This concern is explicitly addressed in the Department of In the future, the AHA/ACC CPGs will explicitly discuss the applicability and quality of recommendations for the most frequent combinations of comorbidities that accompany cardiovascular conditions. An important step in this direction is the collaboration between the AHA/ACC and the Department of Health and Human
Services that includes development of comorbidity data for selected cardiovascular conditions that, in turn, can be included and addressed in CPGs such as the most recent guidelines on atrial fibrillation and heart failure (7,8). The AHA/ACC aim to partner with various organizations to determine how best to highlight and address the complex issues arising from comorbidities in clinical medicine. 
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